For adults with heart failure, when the heart is weak and cannot pump enough blood to the rest of the body (HFrEF), FARXIGA is a prescription medicine approved to reduce the risk of cardiovascular death and hospitalization for heart failure. See more. 

HEART FAILURE BASICS

What is HFrEF?

A healthy heart is a muscular pump that squeezes and relaxes to deliver blood to the body. Heart failure doesn’t mean the heart has stopped. For people with HFrEF (a type of heart failure called “reduced ejection fraction”), it means the heart muscle is weak, so it can’t pump enough blood to keep up with the body’s needs. About half of people with heart failure have HFrEF. Unlike a heart attack, heart failure happens slowly. It’s a chronic condition that gets worse over time, and can lead to hospitalization or death.


THE FACTS ON HEART FAILURE
AND WINDING UP IN THE HOSPITAL IN THE US

Almost
1

million

hospitalizations a year for heart failure


1 in 8

deaths

a year are associated with heart failure


#1

diagnosis

for going back in the hospital within a month

The statistics above reflect the total population of heart failure patients (not just those with HFrEF)





FARXIGA CAN HELP PROTECT PEOPLE WITH A TYPE OF HEART FAILURE BY

Saving lives by reducing risk of cardiovascular death
Saving lives by reducing risk of cardiovascular death
Lowering risk of hospitalizations for heart failure
Lowering risk of hospitalizations for heart failure
Fitting into your current heart failure treatment plan
Fitting into your current heart failure treatment plan

For people being treated for HFrEF:

Ask your doctor how FARXIGA can help
give you added protection

Doctor
Doctor
FARXIGA® (dapagliflozin) Co-pay Card
FARXIGA® (dapagliflozin) Co-pay Card
IMPORTANT SAFETY INFORMATION